Aclaris Therapeutics Inc (ACRS)

04:20 AM

Aclaris Therapeutics Taps Veteran Biotech Leader Roland Kolbeck as New Chief Scientific Officer - MSN

04:20 AM

12:14 PM

Aclaris Therapeutics Reports Q2 Loss, Highlights Progress in Immuno-Dermatology Pipeline - MSN

12:14 PM

07:07 AM

Will Aclaris Therapeutics Inc. outperform the marketPortfolio Risk Summary & Stock Market Timing Techniques - Newser

07:07 AM

03:44 AM

Aclaris Therapeutics Reports Q1 2025 Results and Pipeline Updates - MSN

03:44 AM

Aug 14, 2025

Can trapped investors hope for a rebound in Aclaris Therapeutics Inc.Rate Hike & AI Driven Stock Reports - Newser

Aug 14, 2025

Aug 14, 2025

Combining machine learning predictions for Aclaris Therapeutics Inc.Weekly Profit Summary & Real-Time Buy Signal Alerts - Newser

Aug 14, 2025

Aug 13, 2025

Aclaris Therapeutics Inc. stock trend outlook and recovery pathQuarterly Profit Summary & Real-Time Stock Movement Alerts - Newser

Aug 13, 2025

Aug 12, 2025

How Efficient Is Aclaris Therapeutics Inc. at Controlling Operating CostsPortfolio Building Plan and Summary Guide - Newser

Aug 12, 2025

Aug 11, 2025

Market reaction to Aclaris Therapeutics Inc.’s recent newsCapital Growth Summary Over Five Years - Newser

Aug 11, 2025

Aug 10, 2025

Earnings Update: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Just Reported And Analysts Are Boosting Their Estimates - simplywall.st

Aug 10, 2025

Aug 10, 2025

Earnings Beat: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - uk.finance.yahoo.com

Aug 10, 2025

Aug 09, 2025

Aclaris Therapeutics Reports Q2 2025 Earnings, Highlights Clinical Advancements and Financial Metrics. - AInvest

Aug 09, 2025

Aug 09, 2025

Aclaris Therapeutics (ACRS) Reports Q2 Loss, Beats Revenue Estimates - MSN

Aug 09, 2025

Aug 09, 2025

Aclaris Reports Positive Phase 2a Results for ATI-2138 in Atopic Dermatitis Trial - MSN

Aug 09, 2025

Aug 08, 2025

Aclaris Therapeutics Reports Q2 2025 Results and Updates - TipRanks

Aug 08, 2025

Aug 08, 2025

Ati Inc. shares rise 2.39% premarket after Aclaris Therapeutics reported positive clinical results from Phase 2a trial of ITK/JAK3 inhibitor ATI-2138. - AInvest

Aug 08, 2025

Aug 07, 2025

Aclaris: Q2 Earnings Snapshot - The Washington Post

Aug 07, 2025

Aug 07, 2025

Aclaris Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025

Aug 07, 2025

Aclaris Therapeutics reports Q2 EPS (13c), consensus (13c) - TipRanks

Aug 07, 2025

Aug 07, 2025

Aclaris Therapeutics Inc earnings beat by $0.01, revenue topped estimates - Investing.com India

Aug 07, 2025

Aug 07, 2025

Aclaris Therapeutics shares rise 3.23% premarket after reporting Q2 earnings that met Wall Street expectations. - AInvest

Aug 07, 2025

Aug 07, 2025

Aclaris Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

Aug 07, 2025

Aug 06, 2025

What makes Aclaris Therapeutics Inc. stock price move sharplyFree Trade Scanner With Buy Zone Alerts - Newser

Aug 06, 2025

Aug 04, 2025

Leerink Partners Maintains Aclaris Therapeutics(ACRS.US) With Buy Rating, Maintains Target Price $7 - 富途牛牛

Aug 04, 2025

Aug 04, 2025

Relief Rally in Aclaris Therapeutics Inc. Stock — Can It HoldFree Membership Group - beatles.ru

Aug 04, 2025

Aug 03, 2025

What drives Aclaris Therapeutics Inc. stock priceMaximize your returns with smart trade entries - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How many analysts rate Aclaris Therapeutics Inc. as a “Buy”Invest confidently with professional market insights - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are Aclaris Therapeutics Inc. company’s key revenue driversTriple-digit profit margins - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Aclaris Therapeutics Inc. a growth stock or a value stockDiscover undervalued opportunities early - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the dividend policy of Aclaris Therapeutics Inc. stockCapitalize on emerging market trends - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Aclaris Therapeutics Inc. a good long term investmentCapitalize on market trends before they peak - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What analysts say about Aclaris Therapeutics Inc. stockMarket-leading growth rates - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the risk reward ratio of investing in Aclaris Therapeutics Inc. stockUnmatched profit potential - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are the latest earnings results for Aclaris Therapeutics Inc.Discover market opportunities with expert help - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Wedbush Lowers Earnings Estimates for Aclaris Therapeutics - Defense World

Aug 03, 2025

Aug 03, 2025

What catalysts could drive Aclaris Therapeutics Inc. stock higher in 2025Unlock powerful market analysis and alerts - Jammu Links News

Aug 03, 2025

Aug 01, 2025

Aclaris Therapeutics Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView

Aug 01, 2025

Aug 01, 2025

How volatile is Aclaris Therapeutics Inc. stock compared to the marketBreakout Stocks Watchlist That Work - jammulinksnews.com

Aug 01, 2025

Jul 31, 2025

Is it the right time to buy Aclaris Therapeutics Inc. stockDaily Trading Report For Consistent Profits - Jammu Links News

Jul 31, 2025

Jul 31, 2025

Is Aclaris Therapeutics Inc. stock bottoming outTechnical Screener for High Growth Stocks - Newser

Jul 31, 2025

Jul 31, 2025

Is a relief rally coming for Aclaris Therapeutics Inc. holdersTechnical Stock Breakout Predictions Signal Entry Points - metal.it

Jul 31, 2025

Jul 31, 2025

Analysts Are Bullish on These Healthcare Stocks: Aclaris Therapeutics (ACRS), Nuvation Bio (NUVB) - The Globe and Mail

Jul 31, 2025